Last update 01 Nov 2024
Huiling Pharmaceutical Consulting (Shanghai) Co., Ltd.
Last update 01 Nov 2024
Overview
Tags
Urogenital Diseases
Endocrinology and Metabolic Disease
Hormone
Chemical drugs
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
一项随机、对照、评估者设盲、平行组、多中心试验，旨在比较10 μg或15 μg促卵泡激素δ（FE 999049）与150 IU或225 IU促卵泡激素α（果纳芬）在中国接受辅助生殖技术治疗的女性中作为控制性卵巢刺激常规方案起始剂量的卵巢反应
[Translation] A randomized, controlled, assessor-blinded, parallel-group, multicenter trial to compare ovarian response to 10 μg or 15 μg of follicle-stimulating hormone delta (FE 999049) versus 150 IU or 225 IU of follicle-stimulating hormone alfa (GONA-F) as a starting dose for routine controlled ovarian stimulation in Chinese women undergoing assisted reproductive technology.
一项开放性、随机化、双向交叉、单剂量、生物等效性试验，旨在于健康女性皮下给药后比较高纯度尿促性素注射液（贺美奇®预充注射笔）与注射用高纯度尿促性素（贺美奇®）
[Translation] An open-label, randomized, two-way crossover, single-dose, bioequivalence trial to compare high-purity gonadotropin injection (Hemeiqi® prefilled injection pen) with high-purity gonadotropin for injection (Hemeiqi®) after subcutaneous administration in healthy women.
一项开放性试验评估促性腺激素降调的健康中国女性单次皮下注射FE 999049的药代动力学
[Translation] An open-label trial evaluating the pharmacokinetics of a single subcutaneous injection of FE 999049 in healthy Chinese women with gonadotropin downregulation
100 Clinical Results associated with Huiling Pharmaceutical Consulting (Shanghai) Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Huiling Pharmaceutical Consulting (Shanghai) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Huiling Pharmaceutical Consulting (Shanghai) Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Dec 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
1
Approved
Other
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free